Hypotron

Midodrine Hydrochloride, the active ingredient in Hypotron, is a Alpha-1 adrenergic agonist presented as a oral tablet for oral use. It is used to raise blood pressure in patients with orthostatic or symptomatic hypotension, primarily in adult populations.

GNH USA supplies Hypotron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Midodrine Hydrochloride is indicated for conditions that involve low blood pressure due to autonomic failure or postural changes. - Orthostatic hypotension: increases standing systolic pressure and reduces dizziness when standing. - Symptomatic hypotension: alleviates faintness, fatigue and visual blur caused by low systemic pressure. - Neurogenic hypotension: improves vascular tone in patients with autonomic neuropathy.

Midodrine Hydrochloride may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Piloerection: localized goose‑skin appearance. - Pruritus: itching, especially on the torso. - Urinary retention: difficulty emptying the bladder. - Supine hypertension: elevated blood pressure while lying down. - Headache: mild to moderate intensity. - Nausea: occasional stomach upset.

Serious or Rare Side Effects: - Severe hypertension: rapid, dangerous rise in blood pressure. - Bradycardia: unusually slow heart rate. - Myocardial ischemia: chest pain due to reduced heart blood flow. - Allergic reactions: rash, swelling, or anaphylaxis. - Peripheral ischemia: reduced blood flow to extremities. - Thrombosis: formation of blood clots in vessels.

Before prescribing Midodrine Hydrochloride, clinicians should consider several safety measures. - Blood pressure monitoring: check supine and standing pressures regularly. - Supine positioning: advise patients to avoid lying flat for at least 4 hours after dosing. - Cardiovascular disease: use caution in patients with heart failure or coronary artery disease. - Renal/hepatic function: assess organ function and adjust therapy if needed. - Severe hypertension: discontinue if systolic pressure exceeds 180 mmHg. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Midodrine Hydrochloride can interact with other agents that affect vascular tone or blood pressure.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): additive hypertensive effect. - Other alpha‑1 agonists (e.g., phenylephrine): risk of severe hypertension. - Indirect sympathomimetics (e.g., ephedrine): potentiates vasoconstriction.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance orthostatic hypotension when combined. - Antihypertensive drugs (ACE inhibitors, ARBs): may blunt therapeutic effect. - Beta‑blockers: can mask tachycardia associated with hypertension. - Tricyclic antidepressants: may increase blood pressure variability.